Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasion

This publication has 13 references indexed in Scilit:

• Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer
  Surgical Oncology, 1992
• Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma
  The American Journal of Surgery, 1990
• Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer
  British Journal of Surgery, 1990
• Relaitonship between area of serosal invasion and prognosis in patient with gastric carcinoma
  Cancer, 1987
• Effects of intraperitoneal administration of OK-432 for patients with advanced cancer
  Surgery Today, 1985
• Prognostic significance of intraperitoneal free cancer cells in gastric cancer patients
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1984
• The general rules for the gastric cancer study in surgery and pathology
  Surgery Today, 1981
• The general rules for the gastric cancer study in surgery and pathology
  Surgery Today, 1981
• Clinical studies on cell-mediated immunity in patients with malignant disease I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsivenessin vitro
  Cancer, 1980
• Clinical and pathologic evaluation of patients with recurrence of gastric cancer more than five years postoperatively
  The American Journal of Surgery, 1978